Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInventory AverageInvested CapitalMarket Capitalization

RedHill Biopharma (RDHL) Invested Capital: 2014-2024

Historic Invested Capital for RedHill Biopharma (RDHL) over the last 11 years, with Dec 2024 value amounting to $7.3 million.

  • RedHill Biopharma's Invested Capital fell 1.97% to -$418.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$418.1 million, marking a year-over-year decrease of 1.97%. This contributed to the annual value of $7.3 million for FY2024, which is 37.05% down from last year.
  • Latest data reveals that RedHill Biopharma reported Invested Capital of $7.3 million as of FY2024, which was down 37.05% from $11.7 million recorded in FY2023.
  • In the past 5 years, RedHill Biopharma's Invested Capital registered a high of $95.2 million during FY2020, and its lowest value of $7.3 million during FY2024.
  • Its 3-year average for Invested Capital is $28.6 million, with a median of $11.7 million in 2023.
  • Its Invested Capital has fluctuated over the past 5 years, first skyrocketed by 49.25% in 2020, then plummeted by 82.56% in 2023.
  • Yearly analysis of 5 years shows RedHill Biopharma's Invested Capital stood at $95.2 million in 2020, then decreased by 2.89% to $92.5 million in 2021, then dropped by 27.76% to $66.8 million in 2022, then crashed by 82.56% to $11.7 million in 2023, then crashed by 37.05% to $7.3 million in 2024.